Influence of the Nucleo-Shuttling of the ATM Protein on the Response of Skin Fibroblasts from Marfan Syndrome to Ionizing Radiation
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252212313 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Dagmara Jakubowska und 5 weiteren Autor:innen. Beteiligte Einrichtung: Inserm, U1296 Unit, Radiation: Defense, Health and Environment, 28 rue Laennec, 69008 Lyon, France. Hauptthemen laut MEDLINE: Marfan Syndrome, Ataxia Telangiectasia Mutated Proteins, Fibroblasts, Fibrillin-1. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Haut Commissariat à l'Investissement, Institut National du Cancer, Centre National d'Etudes Spatiales.
Abstract (Originalsprache)
Marfan syndrome (MFS) is an autosomal dominant connective-tissue disorder affecting multiple systems, such as skeletal, cardiovascular, and ocular systems. MFS is predominantly caused by mutations in the FBN1 gene, which encodes the fibrillin-1 protein, crucial for connective-tissue integrity. FBN1 mutations lead to defective fibrillin, resulting in structurally compromised connective tissues. Additionally, these mutations cause aberrant TGF-β expression, contributing to vascular issues and increased susceptibility to radiation-induced fibrosis. Studies about the potential radiosensitivity of MFS are rare and generally limited to case reports. Here, we aimed to investigate the radiation-induced ATM nucleo-shuttling (RIANS) model to explore the molecular and cellular radiation response in fibroblasts from MFS patients. The results showed that the MFS fibroblast cell lines tested are associated with moderate but significant radiosensitivity, high yield of micronuclei, and impaired recognition of DNA double-strand breaks (DSBs) caused by a diminished RIANS. The diminished RIANS is supported by the sequestration of ATM protein in the cytoplasm not only by mutated FBN1 protein but also by overexpressed TGF-β. This report is the first molecular and cellular characterization of the radiation response of MFS fibroblasts and highlights the importance of the FBN1-TGF-β complex after irradiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Inserm, U1296 Unit, Radiation: Defense, Health and Environment, 28 rue Laennec, 69008 Lyon, France.
- Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, ul. Wybrzeże Armii Krajowej 15, 44-100 Gliwice, Poland.
- Département de Biophysique et Médecine Nucléaire, Université Paris Saclay, Versailles St. Quentin-en-Yvelines, 78035 Versailles, France.
ORCID-Profile: Dagmara Jakubowska, Joëlle Al-Choboq, Michel Bourguignon, Dorota Slonina, Nicolas Foray
Förderung
- Haut Commissariat à l'Investissement
- Institut National du Cancer
- Centre National d'Etudes Spatiales
- Polish National Agency for Academic Exchange
- Polish National Science Centre
- Commissariat General à l’Investissement
Zitieren
APA
Jakubowska, D., Al-Choboq, J., Sonzogni, L., Bourguignon, M., Slonina, D., & Foray, N. (2024). Influence of the Nucleo-Shuttling of the ATM Protein on the Response of Skin Fibroblasts from Marfan Syndrome to Ionizing Radiation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212313
Vancouver
Jakubowska D, Al-Choboq J, Sonzogni L, Bourguignon M, Slonina D, Foray N. Influence of the Nucleo-Shuttling of the ATM Protein on the Response of Skin Fibroblasts from Marfan Syndrome to Ionizing Radiation. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212313
BibTeX
@article{Jakubowska2024,
author = {Jakubowska, Dagmara and Al-Choboq, Joëlle and Sonzogni, Laurène and Bourguignon, Michel and Slonina, Dorota and Foray, Nicolas},
title = {Influence of the Nucleo-Shuttling of the ATM Protein on the Response of Skin Fibroblasts from Marfan Syndrome to Ionizing Radiation},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252212313}
}
EUVIMED